Cargando…
Double-Edged Lipid Nanoparticles Combining Liposome-Bound TRAIL and Encapsulated Doxorubicin Showing an Extraordinary Synergistic Pro-Apoptotic Potential
Although TRAIL (TNF-related apoptosis-inducing ligand, also known as Apo2L) was described as capable of inducing apoptosis in transformed cells while sparing normal cells, limited results obtained in clinical trials has limited its use as an anti-tumor agent. Consequently, novel TRAIL formulations w...
Autores principales: | De Miguel, Diego, Gallego-Lleyda, Ana, Martinez-Ara, Miguel, Plou, Javier, Anel, Alberto, Martinez-Lostao, Luis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966652/ https://www.ncbi.nlm.nih.gov/pubmed/31817469 http://dx.doi.org/10.3390/cancers11121948 |
Ejemplares similares
-
Lipid Nanoparticles Decorated with TNF-Related Aptosis-Inducing Ligand (TRAIL) Are More Cytotoxic than Soluble Recombinant TRAIL in Sarcoma
por: Gallego-Lleyda, Ana, et al.
Publicado: (2018) -
Importance of TRAIL Molecular Anatomy in Receptor Oligomerization and Signaling. Implications for Cancer Therapy
por: Naval, Javier, et al.
Publicado: (2019) -
Role of Exosomes in the Regulation of T-Cell Mediated Immune Responses and in Autoimmune Disease
por: Anel, Alberto, et al.
Publicado: (2019) -
Onto better TRAILs for cancer treatment
por: de Miguel, D, et al.
Publicado: (2016) -
DR5 Up-Regulation Induced by Dichloroacetate Sensitizes Tumor Cells to Lipid Nanoparticles Decorated with TRAIL
por: Marco-Brualla, Joaquín, et al.
Publicado: (2023)